LENZ Therapeutics, Inc. (LENZ) Other Operating Expenses (2023)
LENZ Therapeutics (LENZ) has disclosed Other Operating Expenses for 1 consecutive years, with -$71000.0 as the latest value for Q1 2023.
- On a quarterly basis, Other Operating Expenses changed N/A to -$71000.0 in Q1 2023 year-over-year; TTM through Dec 2023 was -$71000.0, a N/A change, with the full-year FY2023 number at -$71000.0, changed N/A from a year prior.
- Other Operating Expenses was -$71000.0 for Q1 2023 at LENZ Therapeutics.
- In the past five years, Other Operating Expenses ranged from a high of -$71000.0 in Q1 2023 to a low of -$71000.0 in Q1 2023.